Discussing risk of recurrence with HR+/HER2- early breast cancer patients

The HCP-Patient Dialogues Initiative has been developed in partnership with a global expert steering committee of oncologists, patient advocates, and a psycho-oncologist. The aim of this initiative is to assist healthcare providers (HCPs) to effectively engage and educate patients with HR+/HER2- early breast cancer on the risk of recurrence, and to help patients understand and adhere to adjuvant therapy.

The communications toolkit consists of one HCP guidance document and two 
patient-facing materials:

This document is adapted for 
home printing, but you can 
also download a full version.